Elevance Health, Inc. (ELV)

The company now

Elevance Health reported third-quarter 2026 operating revenue of $50.4 billion on 21 October 2026, up 0.7 percent from a year earlier 1. Diluted earnings per share were $6.27 and adjusted earnings per share were $6.99, including a net non-operating benefit of $1.85 per share 1.

The benefit expense ratio, the share of premiums paid out for care, improved 70 basis points to 90.6 percent on better Medicare Advantage and Affordable Care Act (ACA) individual plan results 1.

The company raised its 2026 outlook to diluted earnings of at least $22.00 per share, adjusted earnings of at least $29.00 and operating cash flow of at least $6.5 billion 1. It said it expects at least 12 percent growth in adjusted earnings per share in 2027 from a baseline of at least $26.75 5.

Medical membership fell by 487 thousand from a year earlier to about 44.9 million, with losses in Medicaid, Medicare Advantage and risk-based employer plans 1. Operating revenue grew only because premium rates rose 2.

The Centers for Medicare & Medicaid Services (CMS) told the company on 13 July 2026 that no sanctions would be imposed over Medicare Advantage data 2. A Justice Department False Claims Act suit over similar data is still in discovery, due to end on 20 November 2026 2.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.